Idexx Laboratories (IDXX)
Create an Alert
90.88
+1.60 +1.79%
NASDAQ
Jun 17, 8:00PM
BATS Real time
Currency in USD
Idexx Laboratories Revenue Quarterly YoY Growth:
2.92% for March 31, 2013Idexx Laboratories Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 2.92% |
| Dec. 31, 2012 | 4.02% |
| Sept. 30, 2012 | 4.82% |
| June 30, 2012 | 5.60% |
| March 31, 2012 | 10.25% |
| Dec. 31, 2011 | 8.26% |
| Sept. 30, 2011 | 11.62% |
| June 30, 2011 | 12.92% |
| March 31, 2011 | 8.99% |
| Dec. 31, 2010 | 4.96% |
| Sept. 30, 2010 | 4.06% |
| June 30, 2010 | 5.93% |
| March 31, 2010 | 13.56% |
| Dec. 31, 2009 | 11.12% |
| Sept. 30, 2009 | 3.20% |
| June 30, 2009 | -5.29% |
| March 31, 2009 | -5.07% |
| Dec. 31, 2008 | -0.68% |
| Sept. 30, 2008 | 9.46% |
| June 30, 2008 | 18.36% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
IDXX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Abaxis | 16.93% |
| Quidel Corporation | 63.32% |
| Charles River Laboratories International | 1.84% |
IDXX Revenue Quarterly YoY Growth Rankings
| Overall |
75th percentile 4031 of 16773 |
| Sector |
70th percentile 419 of 1408 in Healthcare |
| Industry |
62nd percentile 49 of 130 in Diagnostics & Research |
IDXX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -5.29% | Jun 2009 |
| Maximum | 18.36% | Jun 2008 |
| Average | 6.45% |
